Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042302
Status:
TERMINATED
Last Update Posted:
2012-05-23
First Post:
2002-07-26
Brief Title:
A Double-Blind Randomized Placebo-Controlled Multicenter Phase III Study of Tariquidar PaclitaxelCarboplatin as First-Line Therapy in Non-Small Cell Lung Cancer NSCLC
Sponsor:
QLT Inc
Organization:
QLT Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Non-small Cell Lung Cancer |
| Stage IIIb Non-small Cell Lung Cancer |
Keywords: